Kalpit Patel

Mayank Mamtani

Thomas Flaten

Brandon Folkes

Scott Henry

Jason Wittes

- Journey Medical Corporation entered into a new At Market Issuance Sales Agreement on **August 28, 2025**, allowing it to sell up to **3,750,000 shares** of its common stock through B. Riley Securities, Inc. and Lake Street Capital Markets, LLC.  **[1867066_0001104659-25-084879_tm2524202d2_8kseq1.htm:1]** 
- The company will pay each agent a commission of **3.0%** of the gross proceeds from sales under this new agreement.  **[1867066_0001104659-25-084879_tm2524202d2_8kseq1.htm:1]** 
- This new agreement replaces a previous At Market Issuance Sales Agreement with B. Riley, which was terminated effective **August 28, 2025**.  **[1867066_0001104659-25-084879_tm2524202d2_8kseq1.htm:1]** **[1867066_0001104659-25-084879_tm2524202d2_8kseq1.htm:2]** 
- Under the terminated agreement, the company sold **4,121,318 shares** of common stock between December 30, 2022, and August 28, 2025.  **[1867066_0001104659-25-084879_tm2524202d2_8kseq1.htm:2]**

Journey Medical (DERM)